Clostridium difficile infection in the inflammatory bowel disease patient.
about
The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directionsThe impact of Clostridum difficile on surgical rate among ulcerative colitis patients: A systemic review and meta-analysisFast food fever: reviewing the impacts of the Western diet on immunityClostridium difficile infection in inflammatory bowel disease: challenges in diagnosis and treatment.Clostridium difficile Infection and Fecal Microbiota Transplant.Protective Effect of Carvacrol against Gut Dysbiosis and Clostridium difficile Associated Disease in a Mouse Model.Dietary Behaviors in Psoriasis: Patient-Reported Outcomes from a U.S. National Survey.Clostridium difficile infection worsens the prognosis of ulcerative colitisClostridium difficile and the microbiotaMicrobial composition analysis of Clostridium difficile infections in an ulcerative colitis patient treated with multiple fecal microbiota transplantations.Emergence of fecal microbiota transplantation as an approach to repair disrupted microbial gut ecologyFunctional impacts of the intestinal microbiome in the pathogenesis of inflammatory bowel disease.Donor Recruitment for Fecal Microbiota Transplantation.Human microbiome versus food-borne pathogens: friend or foe.Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease.Hospital discharge abstracts have limited accuracy in identifying occurrence of Clostridium difficile infections among hospitalized individuals with inflammatory bowel disease: A population-based study.Development of gut inflammation in mice colonized with mucosa-associated bacteria from patients with ulcerative colitisEpidemiology, Diagnosis, and Management of Clostridium difficile Infection in Patients with Inflammatory Bowel DiseaseClostridium Difficile Infection Worsen Outcome of Hospitalized Patients with Inflammatory Bowel DiseaseA Prospective Pilot Study on the Systemic Absorption of Oral Vancomycin in Children With Colitis.Clostridium difficile infection: a worldwide disease.Overview of Clostridium difficile infection: implications for ChinaEnvironmental influences on the onset and clinical course of Crohn's disease-part 2: infections and medication use.Treatment of an initial infection with clostridium difficile in patients with inflammatory bowel disease.Stopping, continuing, or restarting immunomodulators and biologics when an infection or malignancy develops.The prevalence of Clostridium difficile infection in pediatric and adult patients with inflammatory bowel disease.Diagnosis and management of common gastrointestinal tract infectious diseases in ulcerative colitis and Crohn's disease patients.Vedolizumab for the treatment of moderately to severely active ulcerative colitis.Diagnostic Yield of Routine Enteropathogenic Stool Tests in Pediatric Ulcerative Colitis.Chemical Genomics, Structure Elucidation, and in Vivo Studies of the Marine-Derived Anticlostridial Ecteinamycin.What to Do When Biologic Agents Are Not Working in Inflammatory Bowel Disease Patients.Linking the Microbiota, Chronic Disease, and the Immune System.Infection-related hospitalizations in the first year after inflammatory bowel disease diagnosis.Development and Validation of a Risk Score for Clostridium difficile Infection in Medicare Beneficiaries: A Population-Based Cohort Study.Fecal microbiota transplantation for Clostridium difficile infection in patients with ileal pouches.Incidence and Risk Factors for Community and Hospital Acquisition of Clostridium difficile Infection in the Tel Aviv Sourasky Medical Center.Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.Frequency and Risk Factors of Clostridium difficile Infection in Hospitalized Patients With Pouchitis: A Population-based Study.Mortality and Costs in Clostridium difficile Infection Among the Elderly in the United States.Risk Factors for Clostridium Difficile Diarrhea in Patients With Solid Organ Transplantation.
P2860
Q26745700-157A7BA6-F7D1-421B-AAEF-538EC06986A0Q26801328-E877D51A-24E6-45ED-BF00-6B18794D8D70Q27028109-E9128C3C-6836-4404-B1F1-CF7A20345321Q30235905-3D095C02-0286-43B7-B4FF-090A551A361CQ30240065-D5E9F0F4-7FCF-489B-A5DB-18FD3CBEB577Q33586133-299ECE4A-8E4A-4909-8E8A-AFC4DF20FFD1Q33752746-2B44ADE3-118F-4110-89BC-7F822CADD305Q34088628-39AB4A8B-184E-458D-B9D0-59BE6631A649Q34311594-057DBFBB-5C3F-4F8F-8E9C-5CF9A40DED7FQ35094756-60C62EA7-DCB9-4EA2-82D1-C8BC609F5DEAQ35221990-B5E7DA7B-A362-43AC-A764-036F5A6BA564Q35271319-3F7CA562-7894-4D3D-B410-47FF82C5E2DEQ35662258-DA69465B-6E9D-45CE-8049-A1982F18BCD2Q35996428-BF21A88B-A827-426F-AD0F-08174C082D1DQ36250322-F136574C-B065-4079-97AD-D8AB86F05502Q36281366-5A414268-671E-4100-9B77-94733E12BF52Q36393719-836C530B-EDA1-4505-8852-462C73D7FAF6Q37014160-948AF426-19A8-44EC-A532-29E95C7E39ADQ37096499-48854839-6244-4ED0-B6AF-1AAC758F1E42Q37406225-B9FB4439-8C3A-4FD6-B9CB-9314FD23D432Q37563993-A0659192-6903-4185-92B2-471174D9AE64Q37609133-52FC3478-CAFB-492F-8BAD-8D797799BF63Q37723798-678365D8-E009-41DE-9689-9F00E7DAD9EEQ38127619-68592D19-837B-48C6-A863-E61D52E068D3Q38197891-DC3C0FD7-5537-44FE-8260-03B4DF14C489Q38208694-2497AB2A-703C-4F4F-902F-721C80B260C3Q38248112-B35EF89F-A3CB-465D-8EE3-697239F714D3Q38425873-C649416C-C5DF-4BD8-B129-8CCC97A36842Q38668473-5D04DB00-4A3F-4F2B-BD8B-0C8C2569BE6CQ38679129-D61A841E-13AF-457C-95AB-47F09ADC1FA2Q38849974-B3B48D67-DF9A-4B22-A00B-D30168A02A18Q38953278-08795C88-8E6A-4B47-8BEE-E689F11A72C4Q39481675-CA3855D7-BE01-4CDF-9362-2B117AC6C228Q39687689-EC79C66E-CB2A-40D7-BEC8-EF5F1B588A26Q40075318-A150FEDF-2AEC-414A-AF70-35A1412598F8Q40180273-53F32A7B-025C-4135-88C2-F6963483AAE9Q40234279-C2CB9893-A478-4B4B-9497-F12D1AC81E0FQ40293106-333340C9-7397-4BA9-9982-354698859D0CQ40496016-B9213A09-22D6-48E6-BABD-F7E0102DD6BFQ40631036-F127C801-B357-4B23-B7BC-F6D9CFE61ECB
P2860
Clostridium difficile infection in the inflammatory bowel disease patient.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Clostridium difficile infection in the inflammatory bowel disease patient.
@ast
Clostridium difficile infection in the inflammatory bowel disease patient.
@en
Clostridium difficile infection in the inflammatory bowel disease patient.
@nl
type
label
Clostridium difficile infection in the inflammatory bowel disease patient.
@ast
Clostridium difficile infection in the inflammatory bowel disease patient.
@en
Clostridium difficile infection in the inflammatory bowel disease patient.
@nl
prefLabel
Clostridium difficile infection in the inflammatory bowel disease patient.
@ast
Clostridium difficile infection in the inflammatory bowel disease patient.
@en
Clostridium difficile infection in the inflammatory bowel disease patient.
@nl
P2860
P921
P356
P1476
Clostridium difficile infection in the inflammatory bowel disease patient
@en
P2093
Adam M Berg
Ciarán P Kelly
P2860
P304
P356
10.1002/IBD.22964
P577
2013-01-01T00:00:00Z